KT&GC Stock Overview
KT&G Corporation, together with its subsidiaries, engages in the production and sale of tobacco and other products in South Korea.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for KT&GC from our risk checks.
KT&G Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩34.80 |
52 Week High | ₩32.40 |
52 Week Low | ₩30.00 |
Beta | 0.14 |
1 Month Change | -0.57% |
3 Month Change | 5.45% |
1 Year Change | 6.10% |
3 Year Change | -2.79% |
5 Year Change | -24.68% |
Change since IPO | 397.14% |
Recent News & Updates
Recent updates
Shareholder Returns
KT&GC | LU Tobacco | LU Market | |
---|---|---|---|
7D | 0.6% | 0% | 0% |
1Y | 6.1% | 0% | 0% |
Return vs Industry: KT&GC exceeded the Luxembourg Tobacco industry which returned -15.4% over the past year.
Return vs Market: KT&GC underperformed the Luxembourg Market which returned 8.9% over the past year.
Price Volatility
KT&GC volatility | |
---|---|
KT&GC Average Weekly Movement | 3.4% |
Tobacco Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in LU Market | 0% |
10% least volatile stocks in LU Market | 0% |
Stable Share Price: KT&GC has not had significant price volatility in the past 3 months.
Volatility Over Time: KT&GC's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | n/a | Bok-In Baek | https://www.ktng.com |
KT&G Corporation, together with its subsidiaries, engages in the production and sale of tobacco and other products in South Korea. It provides tobacco and related materials, reconstituent tobacco sheets, red ginseng, red ginseng products, other health foods, food and beverage products, health functional food products, and cosmetic and related products. The company also offers leaf tobacco cultivation support services; and develops, manufactures, and distributes drugs, bio-pharmaceuticals, over-the-counter medicines, and medical supplies and equipment.
KT&G Corporation Fundamentals Summary
KT&GC fundamental statistics | |
---|---|
Market cap | US$7.85b |
Earnings (TTM) | US$677.23m |
Revenue (TTM) | US$4.36b |
11.6x
P/E Ratio1.8x
P/S RatioIs KT&GC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KT&GC income statement (TTM) | |
---|---|
Revenue | ₩5.86t |
Cost of Revenue | ₩3.07t |
Gross Profit | ₩2.79t |
Other Expenses | ₩1.88t |
Earnings | ₩909.85b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 8.07k |
Gross Margin | 47.61% |
Net Profit Margin | 15.52% |
Debt/Equity Ratio | 6.0% |
How did KT&GC perform over the long term?
See historical performance and comparison